Agenda
To attend the symposium by WebEx, please use this link below:
https://cbiit.webex.com/cbiit/j.php?MTID=ma845bf63dcb90fe785c94de18c0be87e
https://cbiit.webex.com/cbiit/j.php?MTID=ma845bf63dcb90fe785c94de18c0be87e
(Please note, the following times are approximate and all times are ET)
Monday, March 27, 2023
|
|||
---|---|---|---|
Time | Title | Speaker | Affiliation |
8:30 AM | Welcome and opening/housekeeping remarks | Hyun Park | NCI |
8:35 AM | History of the Cytokine Interest Group | Alan Sher | NIAID |
8:45 AM | Reminiscing about Joost Oppenheim | Scott Durum | NCI |
9:00 AM | Joost Oppenheim's family remarks | Oppenheim Family | Family |
9:15 AM | Session 1. Chair: Igal Gery | NEI | |
9:20 AM | So What?" A Guiding Principle; Targeting Host Mediators in Influenza-induced Disease | Stefanie Vogel | U Maryland |
9:40 AM | 35 years since the discovery of protoypic chemotactic cytokines, interleukin-8 and MCAF | Kouji Matsushima | Tokyo University of Science |
10:00 AM | Liver Cancer Heterogeneity | Ning Zhang | Peking Univesity Health Center |
10:20 AM | Round table reminiscent session (Slide Show) | Scott Durum | NCI |
10:30 AM | Coffee Break (30 min) | ||
11:00 AM | Session 2. Chemokines and beyond - Chair: Zack Howard | NIH | |
11:05 AM | Innate Immunity, Inflammation and Cancer: sitting on the shoulders of giants | Alberto Mantovani | Humanitas University |
11:25 AM | The roles of TNFR2+ lymphocytes in regulating triple-negative breast cancer progression. | Adit Ben-Baruch | Tel Aviv University |
11:45 AM | Chemokines: from Joe to the Clinic | Phil Murphy | NIAID |
12:105 PM | Lunch break (50 min) | ||
12:55 PM | Session 3. Chair: Dragana Jankovic | NIAID | |
13:00 PM | TBA | Charles Dinarello | U Colorado |
13:20 PM | The Eye, Microbiota and IL-17 | Rachel Caspi | NEI |
13:40 PM | TNFR2 in activation of Tregs: my scientific journey with Dr. Oppenheim | Xin Chen | University of Macau |
14:00 PM | 2023 CIG Best Paper Awardee talks | Award recipients | |
15:00 PM | Coffee Break (30 min) | ||
15:25 PM | Session 4. Chair: Howard Young | NCI | |
15:30 PM | Chemokine positioning in the extravasation of human pathogenic type 17 T cells | Josh Farber | NIAID |
15:50 PM | IL-1 in Mycobacterium tuberculosis infection | Kat Mayer-Barber | NIAID |
16:10 PM | Deconvolving the many functions of interferons during T cell-mediated viral clearance | Heather Hickman | NIAID |
16:30 PM | From alarmin to TheraVac: Toward the development of an "universal" anti-tumor immunotherapy | De Yang | NCI |
16:50 PM | Closing remarks | Dan McVicar | NCI |